KLF7通过调节SLC1A5-介导的托芬代谢促进肝细胞癌的进展
Bao Chai1, Anhong Zhang2, Yang Liu3
1Department of Gastroenterology, Shanxi Bethune Hospital, Shanxi Academy of Medical sciences, TongilShanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Journal of cellular and molecular medicine
|December 8, 2024
概括
克鲁佩尔样因子7 (KLF7) 通过调节托代谢来促进肝细胞癌 (HCC) 的进展. KLF7上调SLC1A5,影响细胞增殖和迁移,提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 克鲁佩尔样因子7 (KLF7) 是肝细胞癌 (HCC) 中的一个瘤基因.
- 托代谢对HCC进展至关重要.
- KLF7在HCC中调节托代谢中的作用尚不清楚.
研究的目的:
- 调查KLF7在调节HCC中托代谢中的作用.
- 阐明KLF7影响HCC进展的分子机制.
主要方法:
- 在HCC细胞中KLF7的淘汰和过度表达.
- 对与三甲代谢相关的基因 (SLC1A5,SLC7A5,TPH1) 的mRNA和蛋白质水平的分析.
- 测量托和血清激素水平.
- 染色体免疫沉 (ChIP) 试验,以评估KLF7与SLC1A5促进体的结合.
- 在体外和体内测试以评估瘤细胞恶性和生长.
主要成果:
- KLF7 knockdown抑制了托芬代谢,降低了SLC1A5,SLC7A5,TPH1表达和托芬/血清素水平.
- 过度表达KLF7增强了这些因素.
- 血清恢复增加了HCC细胞恶性病和瘤生长;它的减少抑制了增殖.
- KLF7直接与SLC1A5促进体结合,积极调节其表达.
- KLF7通过SLC1A5上调促进HCC的扩散和迁移.
结论:
- KLF7通过调节酸盐代谢,特别是通过KLF7/SLC1A5轴,促进HCC的进展.
- 这种新发现的途径代表了HCC治疗的潜在治疗标.
更多相关视频
10:38Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
3.3K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.8K
相关概念视频
Liver Regeneration
3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
